Market Neuron Logo
⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

JUBLINGREA - Investment Analysis

Last Updated Time : 02 Aug 25, 12:58 am

Back to Investment List

📊 Investment Analysis: Jubilant Ingrevia Ltd. (JUBLINGREA)

Rating: 3.7

Jubilant Ingrevia is a specialty chemicals player with a strong growth strategy and improving fundamentals. While current valuations are elevated, its low debt, rising profitability, and strategic pivot toward high-margin segments make it a promising long-term candidate—provided earnings growth sustains.

✅ Strengths

Strong Growth Strategy: The company’s “Pinnacle 345” plan targets 3x revenue and 4x EBITDA growth over 5 years

1

.

Low Debt-to-Equity (0.26): Financially conservative, enabling reinvestment in capex and R&D

1

.

Quarterly PAT Growth (+153%): Indicates strong operational momentum.

ROCE (11.1%) & ROE (8.87%): Improving efficiency, though not yet best-in-class.

MACD Positive & RSI Neutral (54.2): Bullish technical signals.

DII Holding Surge (+5.90%): Strong domestic institutional confidence.

❌ Concerns

High P/E (51.0) vs Industry PE (34.4): Valuation premium may limit upside.

Negative PEG Ratio (–2.61): Suggests earnings volatility or unreliable growth projections.

Dividend Yield (0.62%): Modest income generation.

FII Holding Decline (–0.16%): Slight dip in foreign investor sentiment.

Trading Above DMA-50 & DMA-200: May be overextended in short term.

🎯 Ideal Entry Price Zone

₹720–₹760 This range aligns with DMA-200 and offers a cushion below current levels. A deeper dip toward ₹690 would be ideal for accumulation.

📈 Strategy for Existing Holders

🕒 Holding Period

3–5 years, especially if ROE improves to >12% and PEG normalizes below 1.0.

Monitor quarterly earnings, margin expansion, and specialty segment growth.

✂️ Exit Strategy

Partial exit near ₹870–₹885, especially if RSI crosses 65 and MACD flattens.

Full exit if

ROE drops below 7%

PAT stagnates for 3+ quarters

PEG remains negative or exceeds 1.5

Dividend yield falls below 0.4%

Would you like to compare Jubilant Ingrevia with peers like Deepak Nitrite or Aarti Industries to assess relative valuation and growth potential? That could sharpen your conviction. 🧪

1

concallanalysis.com

Edit in a page

Back to Investment List